Upgrade to SI Premium - Free Trial

Grifols (GRFS)

7.45 -0.05 (0.67%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

BofA Securities Reiterates Buy Rating on Grifols SA (GRF:SM) (GRFS) September 4, 2026 6:07 AM - StreetInsider Grifols completes patient follow-up in phase 3 alpha-1 lung study August 10, 2026 7:01 AM - StreetInsider Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency August 10, 2026 7:00 AM - Globe NewsWire Form 6-K Grifols SA For: Jul 30 July 30, 2026 10:49 AM - SEC Filing Form 6-K Grifols SA For: Jul 28 July 29, 2026 6:02 AM - SEC Filing Full Article List